NCT00820417View on ClinicalTrials.gov

Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

May 31, 2008

Conditions
Colorectal CancerHead and Neck CancerNon Small Cell Lung Cancer (NSCLC)
Interventions
DRUG

Cetuximab/Gefitinib combination and/or monotherapy

Trial Locations (2)

3000

UZ Gasthuisberg, Leuven

08035

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

lead

Harrison Clinical Research

INDUSTRY